All patients with DM type were administered insulin infusion on admission and 20 with type 2 DM were given insulin due to high glucose (>15 mmol/L) on admission, the rest of the DM patients were given subcutaneous injection according to sliding scale for 48 h after admission. The gene discussed is INS; the disease is diabetes mellitus.